Doximity (NYSE:DOCS) Insider Sells $49,882.04 in Stock

Doximity, Inc. (NYSE:DOCS – Get Free Report) insider Siddharth Sitaram sold 2,444 shares of Doximity stock in a transaction on Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the sale, the insider directly owned 90,706 shares of the company’s stock, valued at $1,851,309.46. This represents a 2.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Siddharth Sitaram also recently made the following trade(s):

Get Doximity alerts:

• On Monday, May 11th, Siddharth Sitaram sold 2,309 shares of Doximity stock. The shares were sold at an average price of $25.77, for a total transaction of $59,502.93.
• On Friday, April 10th, Siddharth Sitaram sold 2,427 shares of Doximity stock. The shares were sold at an average price of $21.09, for a total transaction of $51,185.43.

Doximity Stock Performance

Shares of DOCS stock traded down $0.21 on Wednesday, hitting $20.24. The stock had a trading volume of 3,963,730 shares, compared to its average volume of 3,821,625. The firm has a market cap of $3.70 billion, a price-to-earnings ratio of 20.45, a P/E/G ratio of 3.45 and a beta of 1.30. Doximity, Inc. has a twelve month low of $17.15 and a twelve month high of $76.51. The company has a fifty day simple moving average of $22.49.

Hedge Funds Weigh In On Doximity

Several large investors have recently modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of Doximity by 4.1% during the fourth quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company’s stock valued at $588,281,000 after buying an additional 518,916 shares during the last quarter. UBS Group AG boosted its holdings in Doximity by 26.5% during the fourth quarter. UBS Group AG now owns 680,260 shares of the company’s stock worth $30,122,000 after purchasing an additional 142,408 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in Doximity by 325,436.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,298,891 shares of the company’s stock worth $57,515,000 after purchasing an additional 1,298,492 shares during the last quarter. Blair William & Co. IL boosted its holdings in Doximity by 1,990.7% during the third quarter. Blair William & Co. IL now owns 362,740 shares of the company’s stock worth $26,534,000 after purchasing an additional 345,390 shares during the last quarter. Finally, William Blair Investment Management LLC boosted its holdings in Doximity by 11.7% during the third quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company’s stock worth $426,404,000 after purchasing an additional 609,775 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DOCS. Piper Sandler upped their price target on shares of Doximity from $40.00 to $42.00 and gave the company an “overweight” rating in a research note on Friday, February 20th. Robert W. Baird restated a “neutral” rating and set a $18.00 price objective (down from $40.00) on shares of Doximity in a research report on Thursday, May 14th. The Goldman Sachs Group lowered their price objective on shares of Doximity from $28.00 to $24.00 and set a “neutral” rating for the company in a research report on Thursday, May 14th. Loop Capital set a $31.00 price objective on shares of Doximity in a research report on Tuesday, March 17th. Finally, Freedom Capital upgraded shares of Doximity to a “strong-buy” rating in a research report on Tuesday, March 17th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Doximity has a consensus rating of “Hold” and an average price target of $30.62.

Check Out Our Latest Analysis on DOCS

About Doximity

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.

See Also

• Five stocks we like better than Doximity
• Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
• This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
• Intel Is the Market’s Most Mispriced AI Hedge
• The Biggest Opportunity From SpaceX’s IPO May Surprise You

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.